Results 221 to 230 of about 1,201,269 (362)
In this nationwide inpatient database study of 5229 patients aged 70–79 years who underwent esophagectomy for cancer after neoadjuvant chemotherapy, overlap propensity score weighting analysis showed that neoadjuvant docetaxel‐based triplet regimen (docetaxel, cisplatin, and 5‐fluorouracil) was not associated with a higher incidence of perioperative ...
Yuki Hirano+11 more
wiley +1 more source
482 CRLM patients treated by simultaneous resection were categorized into the young group (age 70 years) and the elderly group (age GreaterEqual;70 years). Although elderly patients receiving simultaneous resection of CRLM have worse OS, similar PFS was reached in the multivariate analysis after propensity score matching.
Qichen Chen+5 more
wiley +1 more source
The effectiveness of intraperitoneal chemotherapy using paclitaxel (i.p.‐PTX) in pancreatic ductal adenocarcinoma (PDAC) patients with peritoneal dissemination remains elusive. This study indicated that the i.p.‐PTX therapy may improve survival in selected patients with PDAC, in particular those with occult peritoneal dissemination.
Tomohisa Yamamoto+33 more
wiley +1 more source
Impact of adjuvant chemotherapy on survival in ypT0-2 N0 rectal cancer. [PDF]
Alorabi MO+6 more
europepmc +1 more source
Exercise training led to significantly greater improvement in exercise capacity in postmenopausal women with aromatase inhibitor‐treated breast cancer than exercise counseling only, none the less it did not exert any measurable effects on endothelial dysfunction Abstract Background Breast cancer is the leading non‐cardiovascular cause of death in women.
Barbara Mayr+3 more
wiley +1 more source
Adjuvant Chemotherapy for High-Risk Stage II Colon Cancer: A Population-Based Study. [PDF]
Butare A+5 more
europepmc +1 more source
Adjuvant chemotherapy for stage II nonseminomatous germ cell cancer of the testis [PDF]
B. J. Kennedy+2 more
openalex +1 more source
PDAC patients with the radiological severe interface (≥25 contact length and ≥210 degrees circumferential tumor‐SMV/PV interface) may help predict poor survival outcomes preoperatively. Abstract Aim To assess the ability of a new severity‐based tumor‐superior mesenteric/portal vein interface criteria to predict survival outcomes in pancreatic ductal ...
Benson Kaluba+9 more
wiley +1 more source
Retesting estrogen receptor and HER2 status provides more clinical benefit than retesting progesterone receptor status. We propose guidelines for retesting receptor profiles to aid patient care management decisions, prioritize clinical benefits, and minimize healthcare costs.
Jessica A. Slostad+5 more
wiley +1 more source